Quarterly report · Q2
5199.TEDINET S100S6PW
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥247m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥373m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥240m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥730m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥370m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥238m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥362m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥517m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥258m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥258m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥11.4bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥11.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥11.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥153m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥772m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥406m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥53m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥76m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥24m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥283m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥676m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥516m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥137 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.02 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.89 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥203.31 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.5 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 32.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥239m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥2m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥459m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥397m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥397m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥486m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥230m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥55m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥601m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥194m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥194m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥11m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥603m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | Prior1YTDDuration | 34000 | JPY |
| Other net inv cf | CurrentYTDDuration | -145000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -23561000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -53026000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -210000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -180666000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -170666000 | JPY |
| Payments of commission for syndicate loan fin cf | Prior1YTDDuration | -1298000 | JPY |
| Payments of commission for syndicate loan fin cf | CurrentYTDDuration | -1592000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -60281000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -47435000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -398000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -15000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -63182000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -62850000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -515827000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -282560000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 21833000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 12838000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -111776000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -169967000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1575326000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1608304000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1463550000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1438337000 | JPY |
| Salaries and bonuses sga | Prior1YTDDuration | 199742000 | JPY |
| Salaries and bonuses sga | CurrentYTDDuration | 202502000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 49220000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 50218000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 8926000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 10119000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000MedicalEquipmentReportableSegmentsMember | 1245794000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000PrecisionEquipmentReportableSegmentsMember | 2596662000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000SPReportableSegmentsMember | 193811000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000FoodContainerMember | 134804000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 4171072000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 4171072000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01109-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01109-000PrecisionEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01109-000SPReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01109-000FoodContainerMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01109-000MedicalEquipmentReportableSegmentsMember | 1245794000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01109-000PrecisionEquipmentReportableSegmentsMember | 2596662000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01109-000SPReportableSegmentsMember | 193811000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01109-000FoodContainerMember | 134804000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |